Shulman Joseph insider trades
Shulman Joseph has filed 33 Form 4s with the SEC that we hold, all for Rhythm Pharmaceuticals, INC. (RYTM), as Chief Technical Officer. Across all of them we count 0 purchases worth $0 and 42 sales worth $15.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 6 sales ($3.7M). The largest single trade was a sale of 48,177 shares of Rhythm Pharmaceuticals, INC. worth $2.4M, dated 2024-02-09. The first filing on our record is dated 2022-02-11 and the latest 2026-08-17.
Rhythm Pharmaceuticals, INC. (RYTM)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-02-15 | S, sale reported on Form 4 | 557 | $3.4K | 2022-02-15 |
| 2023-02-09 | S, sale reported on Form 4 | 931 | $25.6K | 2023-02-14 |
| 2023-02-09 | S, sale reported on Form 4 | 921 | $25.5K | 2023-02-13 |
| 2023-02-14 | S, sale reported on Form 4 | 554 | $14.9K | 2023-02-14 |
| 2023-11-14 | S, sale reported on Form 4 | 27,890 | $894.4K | 2023-11-16 |
| 2023-12-27 | S, sale reported on Form 4 | 5,015 | $250.8K | 2023-12-29 |
| 2023-12-28 | S, sale reported on Form 4 | 7,926 | $396.3K | 2023-12-29 |
| 2024-02-01 | S, sale reported on Form 4 | 1,324 | $59.7K | 2024-02-05 |
| 2024-02-09 | S, sale reported on Form 4 | 48,177 | $2.4M | 2024-02-13 |
| 2024-02-09 | S, sale reported on Form 4 | 100 | $5.2K | 2024-02-13 |
| 2024-02-09 | S, sale reported on Form 4 | 23,397 | $1.2M | 2024-02-13 |
| 2024-02-09 | S, sale reported on Form 4 | 100 | $4.8K | 2024-02-13 |
| 2024-02-12 | S, sale reported on Form 4 | 791 | $40.6K | 2024-02-13 |
| 2024-02-13 | S, sale reported on Form 4 | 1,865 | $93.2K | 2024-02-15 |
| 2024-02-13 | S, sale reported on Form 4 | 473 | $23.6K | 2024-02-13 |
| 2024-02-14 | S, sale reported on Form 4 | 1,089 | $54.5K | 2024-02-15 |
| 2024-03-19 | S, sale reported on Form 4 | 15,515 | $608.5K | 2024-03-19 |
| 2024-03-21 | S, sale reported on Form 4 | 18,235 | $735.6K | 2024-03-22 |
| 2024-05-09 | S, sale reported on Form 4 | 500 | $19.6K | 2024-05-13 |
| 2024-05-09 | S, sale reported on Form 4 | 3,484 | $133.7K | 2024-05-13 |
| 2024-07-12 | S, sale reported on Form 4 | 5,313 | $265.7K | 2024-07-16 |
| 2024-07-16 | S, sale reported on Form 4 | 10,468 | $554.8K | 2024-07-18 |
| 2024-11-11 | S, sale reported on Form 4 | 6,604 | $434.1K | 2024-11-13 |
| 2024-11-11 | S, sale reported on Form 4 | 5,977 | $400.8K | 2024-11-13 |
| 2024-11-11 | S, sale reported on Form 4 | 700 | $47.5K | 2024-11-13 |
| 2025-02-04 | S, sale reported on Form 4 | 1,281 | $76.1K | 2025-02-04 |
| 2025-02-11 | S, sale reported on Form 4 | 3 | $173 | 2025-02-11 |
| 2025-02-11 | S, sale reported on Form 4 | 791 | $45.5K | 2025-02-11 |
| 2025-02-12 | S, sale reported on Form 4 | 462 | $26.1K | 2025-02-14 |
| 2025-02-12 | S, sale reported on Form 4 | 7 | $400 | 2025-02-14 |
| 2025-02-19 | S, sale reported on Form 4 | 1,228 | $70.3K | 2025-02-19 |
| 2025-07-09 | S, sale reported on Form 4 | 3,984 | $301.0K | 2025-07-11 |
| 2025-07-09 | S, sale reported on Form 4 | 3,985 | $318.8K | 2025-07-11 |
| 2025-08-11 | S, sale reported on Form 4 | 3,984 | $358.9K | 2025-08-13 |
| 2025-08-21 | S, sale reported on Form 4 | 4,188 | $419.1K | 2025-08-25 |
| 2025-09-02 | S, sale reported on Form 4 | 16,781 | $1.8M | 2025-09-04 |
| 2025-10-16 | S, sale reported on Form 4 | 3,412 | $384.9K | 2025-10-20 |
| 2025-10-16 | S, sale reported on Form 4 | 8,332 | $933.7K | 2025-10-20 |
| 2025-10-16 | S, sale reported on Form 4 | 2,693 | $298.8K | 2025-10-20 |
| 2025-10-28 | S, sale reported on Form 4 | 2,815 | $323.8K | 2025-10-30 |
| 2025-10-30 | S, sale reported on Form 4 | 9,748 | $1.1M | 2025-11-03 |
| 2026-08-13 | S, sale reported on Form 4 | 5,079 | $608.2K | 2026-08-17 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1909855) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms